• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[翻瓣联合皮质骨穿孔技术在有药物相关性颌骨坏死潜在风险患者拔牙病例中的初步临床效果评估]

[Evaluation of the preliminary clinical effect of flap-raising combined with cortical-perforation technique in tooth extraction cases of patients with potential risk of medication-related osteonecrosis of the jaw].

作者信息

Guo Y X, Wang D C, Liu X J, Wang E B, An J G, Peng X, Guo C B

机构信息

Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China.

出版信息

Zhonghua Kou Qiang Yi Xue Za Zhi. 2021 May 9;56(5):452-457. doi: 10.3760/cma.j.cn112144-20210104-00003.

DOI:10.3760/cma.j.cn112144-20210104-00003
PMID:33904280
Abstract

To evaluate the preliminary clinical effect of flap-raising and cortical-perforation based extraction method in patients with potential risk of medication-related osteonecrosis of the jaw (MRONJ). Eighteen patients, who needed teeth extraction in the Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology from February 2016 to November 2020, with a history of using anti-resorption/anti-angiogenesis medication were included in this retrospective study. According to the characteristics of the patient's medication history, patients were stratified into three categories, low-dose anti-resorption drug group, high-dose anti-resorption drug group, and high-dose anti-resorption combined with anti-angiogenesis targeted drug group. There were 15 females and 3 males, the average age was 62.4 years (range from 27 to 87 years) old. A total of 31 teeth were indicated for extraction due to chronic infection. The flap-raising and cortical-perforation techniques were used to extract the affected teeth, and the patients were followed up closely. By observing the healing status and swelling degree of the mucosa of tooth extraction sites, whether there was a fistula, pus and bone exposure of jaw bone,the healing of the tooth extraction sites were evaluated. Among the 18 patients, there were 9 cases of osteoporosis and 9 cases of malignant tumors. Classified by medication-using history, 10 cases were treated with low-dose anti-resorption drugs, 5 cases were high-dose anti-resorption drugs, and 3 cases were high-dose anti-resorption drugs combined with anti-angiogenesis drugs. A total of 31 teeth of the patients were extracted by flap-raising and cortical-perforation based extraction method. Thirteen patients completed treatment underwent local anesthesia and five cases were performed under general anesthesia. The shortest follow-up period was 3 months with an average of 13.2 months. Seventeen patients recovered well after the tooth extraction. One patient had the mandible exposed at one extraction site one month after the surgery, resulting in MRONJ. In patients with potential risks of MRONJ, the application of flap-raising and cortical-perforation based teeth extraction method could safely and effectively alleviate the dental inflammation in the oral cavity.

摘要

评估翻瓣及皮质骨穿孔拔牙法在有药物相关性颌骨坏死(MRONJ)潜在风险患者中的初步临床效果。纳入2016年2月至2020年11月在北京大学口腔医学院口腔颌面外科需要拔牙且有使用抗骨吸收/抗血管生成药物史的18例患者进行这项回顾性研究。根据患者用药史特点,将患者分为低剂量抗骨吸收药物组、高剂量抗骨吸收药物组和高剂量抗骨吸收联合抗血管生成靶向药物组。其中女性15例,男性3例,平均年龄62.4岁(27~87岁)。因慢性感染共需拔除31颗牙齿。采用翻瓣及皮质骨穿孔技术拔除患牙,并对患者进行密切随访。通过观察拔牙创黏膜愈合情况及肿胀程度、有无瘘管、有无脓性分泌物及颌骨骨质暴露情况,评估拔牙创愈合情况。18例患者中,骨质疏松9例,恶性肿瘤9例。按用药史分类,低剂量抗骨吸收药物治疗10例,高剂量抗骨吸收药物治疗5例,高剂量抗骨吸收联合抗血管生成药物治疗3例。采用翻瓣及皮质骨穿孔拔牙法共拔除患者31颗牙齿。13例患者在局部麻醉下完成治疗,5例在全身麻醉下进行。最短随访时间3个月,平均13.2个月。17例患者拔牙后恢复良好。1例患者术后1个月在1个拔牙创处出现下颌骨暴露,导致MRONJ。对于有MRONJ潜在风险的患者,应用翻瓣及皮质骨穿孔拔牙法可安全有效地缓解口腔内的牙齿炎症。

相似文献

1
[Evaluation of the preliminary clinical effect of flap-raising combined with cortical-perforation technique in tooth extraction cases of patients with potential risk of medication-related osteonecrosis of the jaw].[翻瓣联合皮质骨穿孔技术在有药物相关性颌骨坏死潜在风险患者拔牙病例中的初步临床效果评估]
Zhonghua Kou Qiang Yi Xue Za Zhi. 2021 May 9;56(5):452-457. doi: 10.3760/cma.j.cn112144-20210104-00003.
2
Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.拔牙后进行一期伤口缝合以预防接受地诺单抗治疗患者的药物相关性颌骨坏死
Clin Oral Investig. 2017 Jan;21(1):127-134. doi: 10.1007/s00784-016-1762-y. Epub 2016 Feb 29.
3
Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.药物相关性颌骨坏死:双膦酸盐治疗患者与抗吸收-抗血管生成药物治疗患者的风险因素
Minerva Stomatol. 2017 Aug;66(4):135-140. doi: 10.23736/S0026-4970.17.04056-0. Epub 2017 May 10.
4
Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study.癌症患者拔牙后与药物相关的颌骨坏死:一项多中心回顾性研究。
Osteoporos Int. 2019 Jan;30(1):231-239. doi: 10.1007/s00198-018-4746-8. Epub 2018 Nov 7.
5
Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.抗吸收药物在骨质疏松症患者拔牙中应用与骨坏死的临床和 CBCT 评估:关键见解。
Osteoporos Int. 2024 Aug;35(8):1431-1440. doi: 10.1007/s00198-024-07108-2. Epub 2024 May 20.
6
Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?接受口服或静脉注射双膦酸盐治疗的患者拔牙:引发药物性颌骨坏死的诱因?
J Craniomaxillofac Surg. 2015 Jul;43(6):847-54. doi: 10.1016/j.jcms.2015.03.039. Epub 2015 Apr 10.
7
Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?影响接受大剂量双膦酸盐或地舒单抗治疗的癌症患者药物相关性颌骨坏死发展的因素:拔牙是否为危险因素?
PLoS One. 2018 Jul 26;13(7):e0201343. doi: 10.1371/journal.pone.0201343. eCollection 2018.
8
[Preliminary study on the etiological characteristics and clinical treatment of medication-related osteonecrosis of the jaws].
Zhonghua Kou Qiang Yi Xue Za Zhi. 2021 Jul 9;56(7):659-664. doi: 10.3760/cma.j.cn112144-20210120-00032.
9
[Application of double-layer soft tissue suture closure technique in the surgical treatment of patients with mandible medication-related osteonecrosis of the jaw of early and medium stages].双层软组织缝合关闭技术在下颌骨药物相关性颌骨坏死早中期患者手术治疗中的应用
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Feb 18;56(1):51-56. doi: 10.19723/j.issn.1671-167X.2024.01.009.
10
Incidence and risk factors associated to Medication-Related Osteo Necrosis of the Jaw (MRONJ) in patients with osteoporosis after tooth extractions. A 12-months observational cohort study.拔牙后骨质疏松症患者药物相关性颌骨坏死(MRONJ)的发生率及相关危险因素。一项为期 12 个月的观察性队列研究。
J Stomatol Oral Maxillofac Surg. 2022 Nov;123(6):616-621. doi: 10.1016/j.jormas.2022.03.020. Epub 2022 May 21.